Gabriele La Monica

18PUBLICATIONS
24CO-AUTHORS
Molecular targetsMedical devicesCheminformatics and quantitative structure-activity relationshipsHaematological tumoursBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Jul 28, 2026
Imidazole-Functionalized Thieno[3,2-c]Quinoline Hybrids in Aggressive Medullary Thyroid Cancer Cell Models: Biological Evaluation and in Silico Insights.

|Jun 26, 2026
B.R.E.A.S.T. Breast canceR Enhanced AI-Supported Therapy: A New Interpretable Proteomics-Driven Machine Learning Framework for Therapy Response Prediction in Breast Cancer.

|May 25, 2026
Imidazole-Functionalized Thieno[3,2‑c]quinolines as Promising Antiproliferative Agents: Design, Synthesis, NCI-60 Screening, and Computational Analysis.

|Dec 30, 2025
Tuning Scaffold Properties of New 1,4-Substituted Pyrrolo[3,2-c]quinoline Derivatives Endowed with Anticancer Potential, New Biological and In Silico Insights.

Francesco Mingoia, Caterina Di Sano, Claudia D'Anna

|Oct 29, 2025
A Hybrid In Silico Approach for Identifying Dual VEGFR/RAS Inhibitors as Potential Anticancer and Anti-Angiogenic Agents.

Alessia Bono, Gabriele La Monica, Federica Alamia

|Feb 06, 2025
Design, Synthesis, and In Silico Insights of new 4-Piperazinylquinolines as Antiproliferative Agents against NCI Renal Cancer Cell Lines.

Gabriele La Monica, Alessia Bono, Federica Alamia

Pageof 3

Frequent Collaborators

17 joint publications

Antonino Lauria

17 joint publications

Annamaria Martorana

16 joint publications

Alessia Bono

9 joint publications

Federica Alamia